Abstract
Objective
To evaluate the analgesic effectiveness of two novel regional nerve
blocks in paediatric patients with developmental dysplasia of the hip
(DDH) after open reduction surgeries.
Design
Prospective, double-blinded, randomised controlled trial.
Setting
2 tertiary teaching hospitals in China between August 2017 and July
2018.
Participants
110 paediatric patients aged 2–10 years with DDH undergoing open
reduction surgeries were recruited, 95 were randomised and 90 were
included in the final analysis.
Interventions
Random assignment to quadratus lumborum block III (QLB III) group,
transversalis fascia plane block (TFPB) group and the control (no region
nerve block) group.
Primary and secondary outcome measures
The primary outcome was the Face, Legs, Activity, Cry and
Consolability (FLACC) Scale Scores. Secondary outcomes included
perioperative opioid consumption, the time until first press of
nurse-controlled analgesia/patient-controlled analgesia (NCA/PCA) pump
and the total counts number of pressing, length of postanaesthesia care
unit (PACU) stay, length of hospital stay, parental satisfaction with
pain management and adverse events.
Results
Mean FLACC Scores were significantly lower in QLB III group and TFPB
group while in the PACU and for 48 hours postoperatively, compared with
control group (p<0.0001, p<0.0001, respectively). No differences
were found for FLACC Scores between QLB III group and TFPB group,
neither at rest (p=0.0402) nor while posture changing (p=0.0306). TFPB
prolonged the first-time request for NCA/PCA analgesia, and decreased
the total number of pressing counts, compared with QLB III (22.5 (16.2
to 28.7) vs 11.7 (6.6 to 16.8), p<0.0001; 2.4 (1.3 to 3.6) vs 3.8
(2.8 to 4.8), p=0.0111, respectively). No patient experienced any
adverse events.
Conclusions
We suggested that both ultrasound-guided QLB III and TFPB should be
considered as an option for perioperative analgesia in children with DDH
undergoing open reduction surgeries. TFPB was superior to the QLB III
because it prolonged the first-time request for NCA/PCA analgesia and
decreased the total counts number of pressing.
Trial registration number
NCT03189966/2017.
Funder
National
Natural Science Foundation of China
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献